vinblastine sulfate- vinblastine sulfate injection
fresenius kabi usa, llc - vinblastine sulfate (unii: n00w22yo2b) (vinblastine - unii:5v9klz54cy) - vinblastine sulfate 1 mg in 1 ml - vinblastine sulfate injection is indicated in the palliative treatment of the following: i. frequently responsive malignancies - generalized hodgkin’s disease (stages iii and iv, ann arbor modification of rye staging system) - lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated) - histiocytic lymphoma - mycosis fungoides (advanced stages) - advanced carcinoma of the testis - kaposi’s sarcoma - letterer-siwe disease (histiocytosis x) ii. less frequently responsive malignancies - choriocarcinoma resistant to other chemotherapeutic agents - carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy current principles of chemotherapy for many types of cancer include the concurrent administration of several antineoplastic agents. for enhanced therapeutic effect without additive toxicity, agents with different dose-limiting clinical toxicities and different mechanisms of action are generally selected. therefore, although vinblastine
vinblastine sulfate 1mg/ml solution for injection or infusion
pfizer healthcare ireland - vinblastine sulfate - solution for injection/infusion - 1 milligram(s)/millilitre - vinca alkaloids and analogues; vinblastine
vinblastine sulfate 1 mg/ml solution for inj/inf
hospira uk limited - vinblastine sulfate - solution for inj/inf - 1 mg/ml - vinca alkaloids and analogues
dbl vinblastine injection vinblastine sulfate 10mg/10ml sulfate injection
pfizer australia pty ltd - vinblastine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - used in the treatment of hodgkins' disease (stages iii and iv) in combination therapy (with adriamycin, bleomycin and dacarbazine as abvd) and in the treatment of advanced testicular carcinoma (with cisplatin and bleomycin). in the palliative treatment of lymphocytic lymphoma, histiocytic lymphoma, kaposi's sarcoma and histiocytosis x. advanced stages of mycosis fungoides. may be used in the treatment of choriocarcinoma resistant to other chemotherapeutic agents; carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.
vinblastine sulfate injection solution
sandoz canada incorporated - vinblastine sulfate - solution - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulfate injection solution
pfizer canada ulc - vinblastine sulfate - solution - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulfate 1 mg/ml solution for injection or infusion
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - vinblastine sulfate - solution for injection/infusion - vinblastine sulfate 1 mg/ml - antineoplastic agents
hospira vinblastine sulfate injection 10 mg/10 ml vial
hospira australia pty ltd - vinblastine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; sulfuric acid - vinblastine is indicated in the pallative treatment of the following neoplastic diseases: frequently responsive malignancies; generalized hodgkins disease (stages iii and iv, ann arbor modification of rye), lymphocytic lymphoma (modular and diffuse, poorly and well differentiated), histolocytic lymphoma, mycosis fungoides (advanced stages), advanced carcinoma of the testis, kaposi's sarcoma, letterer-siwe disease(histiocytosis-x), and; less frequently responsive malignancies; choriocarcinoma resistant to other neoplastic drugs and cancer of the breast (unresponsive to endocrine surgery and hormonal therapy)
vinblastine sulfate inj 1mg/ml liquid
david bull laboratories (pty) ltd. - vinblastine sulfate - liquid - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulphate (hospira)
hospira nz ltd - vinblastine sulfate 10mg - powder for injection - 10 mg - active: vinblastine sulfate 10mg excipient: benzyl alcohol sodium chloride water for injection